Ishrana inulinom kao terapija na hemopreventivne i zapaljenske markere tumorogeneze kolorektalnih kancera by Emília, Hijová et al.
519
Acta Veterinaria-Beograd 2014, 64 (4), 519-525
UDK: 615.246; 616.348/.35-006.6-06 
DOI: 10.2478/acve-2014-0048 
Short communication
Corresponding author: e-mail: emilia.hijova@upjs.sk
INULIN DIET INTERVENTION ON CHEMOPREVENTIVE 
AND INFLAMMATORY MARKERS IN TUMORIGENESIS 
OF COLORECTAL CANCER
HIJOVÁ Emília1*, SZABADOSOVA Viktoria2, ŠTOFILOVÁ Jana1, SALAJ Rastislav1, 
BOMBA Alojz1
1Institute of  Experimental Medicine, Medical Faculty, University of  P. J. Šafárik, Košice, Slovak Republic 
2Faculty of  Humanities and Natural Sciences, University of  Prešov in Prešov, Prešov, Slovak Republic
(Received 20 March; Accepted 22 April 2014) 
The aim of  this experiment was to investigate the infl uence of  inulin administration on 
chemopreventive and infl ammatory markers in dimethylhydrazine induced colorectal 
cancer development in rats. A group of  30 Sprague-Dawley rats was divided into a 
control group (CG), a group with dimethylhydrazine (DMH), and a group given 
dimethylhydrazine combined with the prebiotic (DMH+PRE). Dimethylhydrazine 
injection signifi cantly (p<0.001) elevated the immunoreactivity chemopreventive markers 
COX-2, NFκB, iNOS, elevated serum and jejunal mucosa levels of  proinfl ammatory 
cytokine IL-2, and decreased serum and jejunal mucosa levels of  regulatory cytokine 
IL-10. Inulin diet intervention signifi cantly suppressed immunoreactivity of  COX-
2, NFκB, iNOS positive cells in the tunica mucosae and tela submucosae of  rat colon 
tissue, increased levels of  IL-2 and decreased levels of  IL-10. By determining the 
chemopreventive markers COX-2, iNOS and NFkB, which can be characterized as 
infl ammatory markers, we confi rmed the presence of  infl ammation in the colon as 
the number of  COX-2, NFkB and iNOS immunoreactive cells was signifi cantly higher 
after DMH application than in the control group. These fi ndings indicate that dietary 
intake of  inulin suppressed the expression of  the observed markers, which play an 
important role in carcinogenesis and infl ammation, which predispose the use of  inulin 
in the prevention or treatment of  human chronic diseases and its use as a nutritional 
supplement in veterinary medicine.  
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INTRODUCTION
Nowadays, natural substances have been used as alternatives in veterinary medicine with 
increasing frequency [1,2]. Natural dietary compounds such as prebiotics modulate the 
microbial composition and ensure a healthy gastrointestinal tract environment, thus 
they could as potential chemopreventive agents prevent the development colon cancer. 
An association between the development of  cancer and infl ammation has long been 
Acta Veterinaria-Beograd 2014, 64 (4), 519-525
520
appreciated. Infl ammation is now thought to be the key in tumorigenesis via DNA 
damage, stimulation of  the production of  pro-infl ammatory mediators, angiogenesis, 
proliferation, and inhibition of  apoptosis. Indeed, the link between infl ammation and 
development of  colorectal cancer is well-established [3]. Since infl ammation is closely 
linked to tumor promotion, substances with potent anti-infl ammatory activities are 
anticipated to exert chemopreventive effects on carcinogenesis, particularly in the 
promotion stage. Infl ammation may be effectively inhibited by the application of  
suitable immunomodulators. In this regard by improving the intestinal function and 
ensuring a healthy gastrointestinal environment prebiotics represent potential natural 
immunomodulators that attract a great deal of  interest in chemoprevention. 
Chemoprevention is defi ned as the use of  natural dietary compounds and/or synthetic 
substances that can delay, prevent, or even reverse the development of  adenomas, as well 
as the progression from adenoma to carcinoma. The ultimate goal of  chemoprevention 
by natural dietary compounds is the reduction of  colorectal cancer (CRC) incidence 
by intervening on the development pathways in tumor cells which promote growth 
and metastases of  CRC [4]. The aim of  this study was to determine: (a) the effi cacy 
of  the applied prebiotic inulin on the immunoreactivity of  cyclooxygenase-2 (COX-
2), transcription nuclear factor kappa beta (NFκB) and inducible nitric oxide synthase 
(iNOS) in the colon tissue of  rats with dimethylhydrazine (DMH) induced colon 
cancer development; (b) if  inulin supplementation could reduce infl ammatory markers 
IL-2 and IL-10 in the blood serum and jejunal mucosa homogenate of  rats with DMH 
induced colon cancer development.
MATERIAL AND METHODS
Animals and experimental design
Male and female Sprague-Dawley rats were used in accordance with the principles of  
the Care and Use of  Laboratory Animals and approved by the Ethical Committee of  the 
Faculty of  Medicine of  P. J. Šafárik University in Košice. Rats were randomly assigned 
to 3 groups (10 per group): CG control group (with conventional feed), DMH group 
(received DMH, Merck, Germany at a dose of  21 mg/kg body weight subcutaneously 
fi ve times with weekly intervals and conventional feed) and DMH+PRE group 
(received conventional feed, DMH and oligofrucose–enriched inulin, BeneoSynergy 1, 
ORAFTI, Tienen, Belgium at a dose of  80g/kg of  conventional feed). After 7 months 
of  trial the rats were euthanized under anesthesia (Ketamine 100mg/kg + Xylazine 
15 mg/kg body weight, i.p.) blood samples were taken by cardiac puncture and tissue 
samples were taken from the jejunum and colon.
Assessment of cytokine levels in the blood serum
and jejunal homogenates 
The serum levels of  interleukins (ILs), IL-2 and IL-10 were measured by ELISA 
(eBioscience, USA) according to the manufacturer´s directions. The segment of  the 
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jejunum was taken, fl ushed with ice-old PBS (pH 7.2) solution, opened longitudinally. 
The frozen scraped jejunal mucosa was homogenized with a homogenizer in PBS 
solution and centrifuged at 12,000g for 20 min. at 4°C. The supernatant was collected 
and used in order to measure levels of  IL-2 and IL-10 according to the instructions 
provided by the ELISA kits manufacturer.
Immunohistochemical analysis of the chemopreventive 
markers COX-2, NFκB, iNOS in the colon tissue   
Immunohistochemical staining of  markers COX-2, NFκB and iNOS in the colon 
tissue was performed on 4-5 μm paraffi n sections using a commercial kit HRP-DAB 
Cell & Tissue Staining Kit (R&D Systems, UK). Immunoreactivity in the tunica mucosae 
and in the tela submucosae of  the colon was localized by immunohistochemistry using 
specifi c anti-COX-2 antibodies (diluted 1:500; Abcam, UK), anti-NFκB (diluted 
1:100; MBL International, USA) and anti-iNOS (diluted 1:5000; Sigma Aldrich, Czech 
Republic). Immunoreactivity of  COX-2, NFκB and iNOS was expressed as the total 
number (average of  tunica mucosae and tela submucosae) of  positive cells calculated to 
the area of  1000 μm2  tissue of  the colon. 
Statistical analysis
Results are expressed as mean ± standard deviation (SD). Statistical analysis was 
performed using analysis of  variance (ANOVA) with p values (p<0.05) considered to 
be statistically signifi cant.
RESULTS AND DISCUSSION
Our results indicate that undigested food such as prebiotics fermented in the colon by 
the microbiota give rise to various microbial metabolites mainly short-chain fatty acids 
(SCFA), including acetic, propionic and butyric acid [5]. Propionic acid is produced 
by fermentation of  polysaccharides and oligosaccharides by the anaerobic colonic 
microbiota. It has a moderate inhibitory activity on cyclooxygenase, hence the direct 
anti-infl ammatory effect of  propionic acid via cyclooxygenase is to be expected and 
this is (or could be) a likely mechanism for the down-regulation of  low-grade mucosal 
infl ammation by prebiotic diets. 
Enhanced expression of  COX-2, which is an important enzyme that mediates 
infl ammatory processes, has been observed in many different types of  tumors and 
transformed cells [6]. The provided proof  is the fi nding of  the highest total number 
of  COX-2 positive cells in the colon tissue in the DMH group with induced colon 
cancer development (Figure 1). Similar changes in the DMH group were recorded 
in the total numbers of  NFкB and iNOS positive cells in the colon tissue (p<0.001). 
The increased concentrations of  proinfl ammatory cytokine IL-2 and the suppressed 
levels of  the regulatory cytokine IL-10 in DMH group are associated with chronic 
infl ammation which is closely linked to tumor promotion (Figure 2). 
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Dietary supplementation with the prebiotic inulin reduced the infl ammatory 
response present in the serum and jejunal mucosa by inhibiting the production of  
the pro-infl ammatory IL-2 and stimulating the regulatory IL-10 which shows its anti-
infl ammatory activity and immune enhancing effect [7]. The applied inulin decreased 
the total numbers of  COX-2, NFκB and iNOS positive cells (COX-2: NFκB 
r=0.583; NFκB:iNOS r=0.939). Recent studies demonstrated that the regulation 
of  COX-2  involves the transcription nuclear factor-kappa beta (NFκB) [8]. Several 
chemopreventive phytochemicals have been shown to inhibit COX-2 by blocking 
improper NFκB activation. The transcriptional activity of  NFκB is regulated via 
an elaborate series of  intracellular signal tranduction events in response to external 
stimuli such as mitogens and infl ammatory cytokines [9]. In addition to its central 
role in mediating infl ammation, NFκB is important in controlling cell proliferation, 
oncogenesis and cell transformation and has drawn much interest as an attractive 
therapeutic target for novel anti-infl ammatory and immunomodulatory drugs [10]. 
Inactivation of  NFkB in tumor processes supports the reduction of  the incidence and 
size of  tumors [11]. The effect of  prebiotics on the activity of  NFkB is affected by 
butyric acid. Changing the composition of  the microfl ora also affects the activation 
Figure 1. COX-2, NFkB and iNOS total numbers of  positive cells in colon tissue. Statistical 
signifi cance is comparison CG/DMH and DMH/DMH+PRE, *p<0.05, ***p<0.001
Figure 2. Serum and jejunal IL-2 and IL-10 levels. Statistical signifi cance is 
comparison CG/DMH and DMH/DMH+PRE, ***p<0.001
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of  NFkB, for example Eubacterium and Bifi dobacterium are able to inactivate 
NFkB.  The enzyme activated through NFkB that plays a pivot role  in mediating 
infl ammation especially when it interacts with COX-2 is iNOS. It is beleived that 
chronic infl ammation and repeated production of  NO by iNOS leads to neoplastic 
transformation, a key step in the process of  carcinogenesis. Increased expression of  
iNOS in DMH-induced group was probably due to a positive regulation of  the NOS2 
gene, which codes iNOS [12]. 
CONCLUSION
By determinig COX-2, iNOS and NFkB which can be characterized as good targets 
for chemoprevention of  colon cancer as well as infl ammatory markers, we confi rmed 
the presence of  infl ammation in the colon. The number of  COX-2, NFkB and iNOS 
immunoreactive cells was signifi cantly higher after DMH application than in the 
control group [13]. All  detected changes were also seen in others studies on DMH-
induced carcinogenesis in rats, but also in carcinogenesis in humans and confi rm 
that activation of  infl ammatory signaling pathways are infl uenced by DMH and are 
the evidence of  the interaction of  chronic infl ammation with carcinogenesis. Inulin 
supressed the expression of  the observed markers, thus predisposing the use of  inulin 
in the prevention or treatment of  human chronic diseases and promoting inulin as a 
nutritional supplement in veterinary medicine.   
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ISHRANA INULINOM KAO TERAPIJA NA 
HEMOPREVENTIVNE I ZAPALJENSKE MARKERE 
TUMOROGENEZE KOLOREKTALNIH KANCERA
HIJOVÁ Emília, SZABADOSOVA Viktoria, ŠTOFILOVÁ Jana, SALAJ Rastislav, 
BOMBA Alojz
Obavljeno je ispitivanje uticaja davanja inulina na hemopreventivne i zapaljenske 
markere kod kolorektalnih kancera izazvanih dimetilhidrazinom kod pacova. Ukupno 
je 30 Sprague-Dawley pacova podeljeno na kontrolu grupu (CG), dimetilhidrazin grupu 
(DMH) i grupu koja je primila dimetilhidrazin zajedno sa prebiotikom (DMH+PRE). 
Injekcija dimetilhidrazina je značajno (p<0.001) povećavala imunoreaktivnost hemo-
preventivnih markera COX-2, NFκB, iNOS, povećavajući koncentracije proinfl ama-
tornih citokina IL-2 u serumu i jejunalnoj mukozi uz smanjenje koncentracije regula-
tornih citokina IL-10 u serumu i jejunalnoj mukozi. Davanje inulina u hrani, značajno 
je suprimiralo imunoreaktivnost COX-2, NFκB i iNOS pozitivnih ćelija u tunica mucosae 
i tela submucosae tkiva kolona pacova, povećavajući koncentracije IL-2 i smanjujući kon-
centracije IL-10. Određujući hemopreventivne markere COX-2, NFκB i iNOS, koji 
mogu da se defi nišu i kao zapaljenski markeri, potvrdili smo prisustvo zapaljenske 
reakcije u kolonu s obzirim da je broj COX-2, NFκB i iNOS imunoreaktivnih ćelija 
bio značajno povećan posle aplikacije DMH u poređenju sa kontrolnom grupom. Re-
zultati ukazuju da davanje inulina u hrani vrši supresiju  ekspresije posmatranih mar-
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kera koji imaju značajnu ulogu u karcinogenezi i zapaljenskoj reakciji, što ukazuje da 
inulin ima značajnu ulogu u prevenciji ili terapiji hroničnih oboljenja kod ljudi kao i da 
je važna primena inulina kao dodatka u ishrani u veterinarskoj medicini.
